Stadarbergi 2-4
IS-221 Reykjanesbaer
Iceland Languages we speak: English , Spanish
, Icelandic , Norwegian Registration number# 6203911079 Number of employees 60
CERTIFICATE OF AUTHENTICATONThis badge is granted by Icelandic EXPORT and guarantee the authenticity of the information provided by this company.
You can trust information listed with Icelandic EXPORT.
Stofnfiskur is a leading company in selective breeding and production of eyed salmon eggs. The company is unique in being
Stofnfiskur is a leading company in selective breeding and production of eyed salmon eggs. The company is unique in being able to supply salmon eggs on a year-round basis. Another crucial advantage is Iceland´s track record for the level of fish diseases, which is lower than anywhere else in the world. On-going involvement in research and breeding projects ensures that this excellent performance will continue. Stofnfiskur´s main activities are: Egg production, selective breeding, research services and consultancy. Stofnfiskur is the largest producer of eyed salmon eggs in Iceland, where conditions for fish farming are unrivalled. The company takes advantage of ample geothermal resources to control the temperature and saline content of the water - crucial factors in aquaculture. Controlling these factors will improve results from selective breeding, by allowing optimum spawning time to be achieved. Egg quality is constantly being improved through the company´s extensive breeding programmes for salmon, both in Iceland, Ireland (Stofnfiskur Ireland Ltd.), Scotland and Chile (Saga Chile). Other established products include Arctic Charr ova. Stofnfiskur is also in collaboration with other companies and institutes in Iceland regarding the selective breeding of cod through the company ICECOD
deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE
deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery - our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease. The company currently has seven lead programs in drug discovery and development and is broadening its pipeline through gene and target discovery work in 50 of the most common diseases
ORF Genetics has pioneered a unique approach for manufacturing recombinant proteins. Using its proficient OrfeusTM system the company is the
ORF Genetics has pioneered a unique approach for manufacturing recombinant proteins. Using its proficient OrfeusTM system the company is the only one able to provide biorisk-freeTM growth factors and cytokines for medical research, cosmetics, cell culture